Edit Code of Life, Creating Transformative Solutions for Serious Human Diseases

> About Us> Leadership

Bo ZhangPh.D.

Head of US Subsidiary

Dr. Bo Zhang has around 20 years of experience in research and drug development in both industry and academia in the US. He joined EdiGene in 2020 as Head of US Subsidiary. 

Prior to joining EdiGene, he was Vice President of KLUS Pharma and focused on cell therapy and new technologies. Before that, he was Director of Development at Cobalt Biomedicine leading CAR-T and other cell/gene therapy programs, and R&D Director at OvaScience developing stem cell-based products. Prior to that, he held various oncology research and development positions at Merrimack Pharmaceuticals and Archemix.

Dr. Zhang completed his postdoctoral fellowship at Harvard Medical School/Boston Children’s Hospital. He received his B.S. degree from Henan Normal University, M.S. degree from Chinese Academy of Sciences and Ph.D. from University of New Hampshire.